BackPhaseBio Pharmaceuticals Overview

PhaseBio Pharmaceuticals Gross Profit

Gross Profit analysis for PHAS.

Quarterly Gross Profit

$208000.00
↓ 97.99% YoY

As of Jun 30, 2022

Annual Gross Profit (TTM)

$818000.00
↓ 92.27% YoY

Trailing 12 months ending Jun 30, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin